DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HEXAMIDINE
4
Small molecule
Approved
Unknown
Unknown
Eye Infections; Nasal Obstruction
Unknown
HEXAMIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
3483C2H13H
Molecule Type:
Small molecule
Molecular Formula:
C20H26N4O2
Molecular Weight:
354.45
AlogP:
3.27
PSA:
118.2
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMIVANTAMAB-VMJW
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
AMIVANTAMAB-VMJW
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIATRIZOATE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION; URETERAL; URETHRAL
Ileus
Diagnostic agent
DIATRIZOATE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
3X9MR4N98U
Molecule Type:
Small molecule
Molecular Formula:
C18H26I3N3O9
Molecular Weight:
809.13
AlogP:
3.12
PSA:
95.5
HBD:
3.0
HBA:
#RotB:
3.0
Source:
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FENTICONAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FENTICONAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
QG05NRB077
Molecule Type:
Small molecule
Molecular Formula:
C24H20Cl2N2OS
Molecular Weight:
455.41
AlogP:
7.3
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
8.0
Source:
DOCETAXEL
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
DOCETAXEL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
4
Combination
Approved
OTHER
VAGINAL
Unknown
Unknown
TRIPLE SULFA (SULFABENZAMIDE;SULFACETAMIDE;SULFATHIAZOLE)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RAVULIZUMAB-CWVZ
4
Antibody
Approved
Unknown
INJECTION
Unknown
Unknown
RAVULIZUMAB-CWVZ
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
4
Combination
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
AMINO ACIDS; CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM GLYCEROPHOSPHATE; SOYBEAN OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BROMHEXINE
4
Small molecule
Approved
Unknown
Unknown
Malaria; Severe Acute Respiratory Syndrome
Unknown
BROMHEXINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Q1J152VB1P
Molecule Type:
Small molecule
Molecular Formula:
C14H20Br2N2
Molecular Weight:
376.14
AlogP:
4.56
PSA:
29.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MECOBALAMIN
4
Small molecule
Approved
Unknown
Unknown
Amyotrophic Lateral Sclerosis; Diabetes Mellitus, Type 2; Vitamin B 12 Deficiency; Anemia
Unknown
MECOBALAMIN
×
Maximum Phase:
4
First Approval:
None
UNII:
BR1SN1JS2W
Molecule Type:
Small molecule
Molecular Formula:
C63H91CoN13O14P
Molecular Weight:
1344.4
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DIFEMERINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
DIFEMERINE
×
Maximum Phase:
4
First Approval:
None
UNII:
843C4UPZ2F
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO3
Molecular Weight:
327.42
AlogP:
2.81
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
6.0
Source:
THIOCTIC ACID
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
THIOCTIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYCLOBARBITAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CYCLOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
0M8A98AD9H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N2O3
Molecular Weight:
236.27
AlogP:
1.25
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
SPARTEINE
4
Small molecule
Approved
Unknown
Unknown
Arrhythmias, Cardiac
Unknown
SPARTEINE
×
Maximum Phase:
4
First Approval:
None
UNII:
298897D62S
Molecule Type:
Small molecule
Molecular Formula:
C15H26N2
Molecular Weight:
234.39
AlogP:
2.35
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
0.0
Source:
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
4
Combination
Approved
OTHER
ORAL; ORAL SUSPENSION
Unknown
Unknown
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZIODARONE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Calmodulin inhibitor
BENZIODARONE
×
Maximum Phase:
4
First Approval:
None
UNII:
75CL65GTYR
Molecule Type:
Small molecule
Molecular Formula:
C17H12I2O3
Molecular Weight:
518.09
AlogP:
5.14
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BARBITAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
5WZ53ENE2P
Molecule Type:
Small molecule
Molecular Formula:
C8H12N2O3
Molecular Weight:
184.19
AlogP:
0.16
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ZINC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
ZINC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBENICILLIN PHENYL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CARBENICILLIN PHENYL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
18N5JP36GY
Molecule Type:
Small molecule
Molecular Formula:
C23H21N2NaO6S
Molecular Weight:
476.49
AlogP:
2.01
PSA:
113.01
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; TYROSINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MENOTROPINS (FSH;LH)
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
MENOTROPINS (FSH;LH)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROPYLIODONE
4
Small molecule
Approved
OTHER
INTRATRACHEAL
Unknown
Unknown
PROPYLIODONE
×
Maximum Phase:
4
First Approval:
None
UNII:
5NPJ6BPX36
Molecule Type:
Small molecule
Molecular Formula:
C10H11I2NO3
Molecular Weight:
447.01
AlogP:
2.01
PSA:
48.3
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PHENAZOCINE HYDROBROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PHENAZOCINE HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
C1749020IH
Molecule Type:
Small molecule
Molecular Formula:
C22H28BrNO
Molecular Weight:
402.38
AlogP:
4.16
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PETROLEUM JELLY
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
PETROLEUM JELLY
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
POTASSIUM CHLORIDE; SODIUM CHLORIDE; TROMETHAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOTEPREDNOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LOTEPREDNOL
×
Maximum Phase:
4
First Approval:
None
UNII:
I3T12NR296
Molecule Type:
Small molecule
Molecular Formula:
C20H26O5
Molecular Weight:
346.42
AlogP:
2.08
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
MEBEVERINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MEBEVERINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
15VZ5AL4JN
Molecule Type:
Small molecule
Molecular Formula:
C25H36ClNO5
Molecular Weight:
466.02
AlogP:
4.6
PSA:
57.23
HBD:
0.0
HBA:
#RotB:
13.0
Source:
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
4
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PHARMACOLOGY
BUCCAL; SUBLINGUAL
Unknown
Unknown
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
4
Combination
Approved
Unknown
SUBCUTANEOUS
Unknown
Unknown
RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
4
Combination
Approved
OTHER
ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
281
282
283
284
285
286
287
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA